Form 8-K - Current report:
SEC Accession No. 0000950170-25-002193
Filing Date
2025-01-06
Accepted
2025-01-06 16:31:36
Documents
11
Period of Report
2025-01-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K rapt-20250103.htm   iXBRL 8-K 37115
  Complete submission text file 0000950170-25-002193.txt   146304

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rapt-20250103.xsd EX-101.SCH 23868
13 EXTRACTED XBRL INSTANCE DOCUMENT rapt-20250103_htm.xml XML 4535
Mailing Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 489-9000
RAPT Therapeutics, Inc. (Filer) CIK: 0001673772 (see all company filings)

EIN.: 473313701 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38997 | Film No.: 25511642
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)